These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1461 related articles for article (PubMed ID: 36045691)
1. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas. Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP Front Immunol; 2022; 13():933973. PubMed ID: 36045691 [TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas. Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200 [TBL] [Abstract][Full Text] [Related]
4. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma. Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X Front Oncol; 2023; 13():1152681. PubMed ID: 37333810 [TBL] [Abstract][Full Text] [Related]
5. Cuproptosis-related gene-located DNA methylation in lower-grade glioma: Prognosis and tumor microenvironment. Zhu L; Yuan F; Wang X; Zhu R; Guo W Cancer Biomark; 2024; 40(2):185-198. PubMed ID: 38578883 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma. Zhang B; Wang Q; Zhang T; Zheng Z; Lin Z; Zhou S; Zheng D; Chen Z; Zheng S; Zhang Y; Lin X; Dong R; Chen J; Qian H; Hu X; Zhuang Y; Zhang Q; Jin Z; Jiang S; Ma Y Front Cell Dev Biol; 2023; 11():1159355. PubMed ID: 37152283 [No Abstract] [Full Text] [Related]
7. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer. Song S; Zhang M; Xie P; Wang S; Wang Y Front Immunol; 2022; 13():978909. PubMed ID: 36341328 [TBL] [Abstract][Full Text] [Related]
8. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients. Yang H; Yang J; Bian H; Wang X Front Pediatr; 2022; 10():1049858. PubMed ID: 36568423 [TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics. Zhang Z; Wang B; Xu X; Xin T Front Genet; 2022; 13():1036460. PubMed ID: 36386799 [TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201 [TBL] [Abstract][Full Text] [Related]
11. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma. Li J; Yin J; Li W; Wang H; Ni B Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in lung adenocarcinoma. Xiaona X; Liu Q; Zhou X; Liang R; Yang S; Xu M; Zhao H; Li C; Chen Y; Xueding C Comput Biol Med; 2023 May; 158():106831. PubMed ID: 37037146 [TBL] [Abstract][Full Text] [Related]
13. Crosstalk of cuproptosis-related subtypes, establishment of a prognostic signature, and immune infiltration characteristics in gastric cancer. Wang Y; Guo F; Song W; Guo W; Shao J; Liu Y Heliyon; 2024 Jan; 10(2):e24411. PubMed ID: 38298669 [TBL] [Abstract][Full Text] [Related]
14. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma. Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C Front Genet; 2023; 14():1124439. PubMed ID: 36936439 [No Abstract] [Full Text] [Related]
15. A cuproptosis-based prognostic model for predicting survival in low-grade glioma. Zhao Z; Ma Y; Liu Y; Chen Z; Zheng J Aging (Albany NY); 2024 May; 16(10):8697-8716. PubMed ID: 38738989 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer. Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115 [TBL] [Abstract][Full Text] [Related]
17. Molecular Subtypes Based on Cuproptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer. Huang H; Long Z; Xie Y; Qin P; Kuang L; Li X; Zhao Y; Zhang X; Yang L; Ma W; Xiao X; Liu Y; Sun X; Zhang M; Wang F; Hu D; Hu F J Oncol; 2022; 2022():5034092. PubMed ID: 36276275 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma. Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226 [TBL] [Abstract][Full Text] [Related]
19. Identification of Cuproptosis-Related Subtypes in Lung Cancer, Characterization of Tumor Microenvironment Infiltration, and Establishment of a Prognostic Model. Cui J; Xiong Y; Liu Y; Sun M; Gu X; Zhong L; Hong X; Liu L Biomed Res Int; 2022; 2022():7406636. PubMed ID: 36588537 [TBL] [Abstract][Full Text] [Related]
20. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance. Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]